Literature DB >> 15059890

ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation.

Tom Stiff1, Mark O'Driscoll, Nicole Rief, Kuniyoshi Iwabuchi, Markus Löbrich, Penny A Jeggo.   

Abstract

H2AX phosphorylation is an early step in the response to DNA damage. It is widely accepted that ATM (ataxia telangiectasia mutated protein) phosphorylates H2AX in response to DNA double-strand breaks (DSBs). Whether DNA-dependent protein kinase (DNA-PK) plays any role in this response is unclear. Here, we show that H2AX phosphorylation after exposure to ionizing radiation (IR) occurs to similar extents in human fibroblasts and in mouse embryo fibroblasts lacking either DNA-PK or ATM but is ablated in ATM-deficient cells treated with LY294002, a drug that specifically inhibits DNA-PK. Additionally, we show that inactivation of both DNA-PK and ATM is required to ablate IR-induced H2AX phosphorylation in chicken cells. We confirm that H2AX phosphorylation induced by DSBs in nonreplicating cells is ATR (ataxia telangiectasia and Rad3-related protein) independent. Taken together, we conclude that under most normal growth conditions, IR-induced H2AX phosphorylation can be carried out by ATM and DNA-PK in a redundant, overlapping manner. In contrast, DNA-PK cannot phosphorylate other proteins involved in the checkpoint response, including chromatin-associated Rad17. However, by phosphorylating H2AX, DNA-PK can contribute to the presence of the damage response proteins MDC1 and 53BP1 at the site of the DSB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15059890     DOI: 10.1158/0008-5472.can-03-3207

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  399 in total

1.  BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair.

Authors:  Ismail Hassan Ismail; Christi Andrin; Darin McDonald; Michael J Hendzel
Journal:  J Cell Biol       Date:  2010-10-04       Impact factor: 10.539

2.  Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair.

Authors:  Dana A Löser; Atsushi Shibata; Akiko K Shibata; Lisa J Woodbine; Penny A Jeggo; Anthony J Chalmers
Journal:  Mol Cancer Ther       Date:  2010-06-08       Impact factor: 6.261

3.  Telomere shortening alters the kinetics of the DNA damage response after ionizing radiation in human cells.

Authors:  Rachid Drissi; Jing Wu; Yafang Hu; Carol Bockhold; Jeffrey S Dome
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-19

4.  Deregulation of DNA damage response pathway by intercellular contact.

Authors:  Meyke Ausman Kang; Eui-Young So; Toru Ouchi
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

5.  Terminally differentiated astrocytes lack DNA damage response signaling and are radioresistant but retain DNA repair proficiency.

Authors:  L Schneider; M Fumagalli; F d'Adda di Fagagna
Journal:  Cell Death Differ       Date:  2011-10-07       Impact factor: 15.828

6.  Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining.

Authors:  Anastazja Grabarz; Aurélia Barascu; Josée Guirouilh-Barbat; Bernard S Lopez
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

7.  Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.

Authors:  Atsushi Shibata; Olivia Barton; Angela T Noon; Kirsten Dahm; Dorothee Deckbar; Aaron A Goodarzi; Markus Löbrich; Penny A Jeggo
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

8.  DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.

Authors:  Stela S Palii; Beth O Van Emburgh; Umesh T Sankpal; Kevin D Brown; Keith D Robertson
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

Review 9.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

10.  Cisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells.

Authors:  P O Carminati; F S Donaires; M M Marques; E A Donadi; G A S Passos; E T Sakamoto-Hojo
Journal:  Mol Biol Rep       Date:  2013-11-12       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.